4L7;
`
`Ana 1 r 2018 a
`Lu
`9
`
`4
`'73}
`'?
`
`-'
`
`‘
`
`~
`
`.
`
`,
`
`PTO/AIA/22 (03-13)
`Approved for use through 7/31/2016. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`-ersons are re-uired to res-0nd to a collection of information unless it disla s a valid OMB control number.
`Docket Number (Optional)
`
`PETITION FOR EXTENSION OF TIME UNDER 37 CFR1.136(a)
`
`13512700006/JMC/MSB
`
`Application Number 1 5/708,991
`
`Filed September 19, 2.017
`
`~
`.i
`
`ForBuprenorphine-Wafer for Drug Substitution Therapy
`Anunit1628
`ExaminerRicci, Craig D.
`This is a request under the provisions of 37 CFR 1.136(a) to extend the period for filing a reply in the above-identified application.
`
`The requested extension and fee are as follows (check time period desired and enter the appropriate fee below):
`
`One month (37 CFR1.17(a)(1))
`
`Two months (37 CFR 1.17(a)(2))
`Three months (37 CFR 1.17(a)(3))
`
`Four months (37 CFR 1.17(a)(4))
`
`Five months (37 CFR 1.17(a)(5))
`
`_F_e_e_
`
`$200
`
`$600
`$1,400
`
`$2,200
`
`$3.000
`
`Small Entity Fee
`
`Micro Entity Fee
`
`$100
`
`$300
`$700
`
`$1,100
`
`$1.500
`
`$50
`
`$150
`$350
`
`$550
`
`$750
`
`5
`
`$
`$ 1400'00
`
`$
`
`$
`
`
`
`7FR..
`.
`.
`m
`A [C
`ppi ant assertss all entity status See3 C
`127
`
`[:1
`
`.........
`.,
`u
`-4/3’1/531.
`-_,
`3...}!
`
`32333325 15 33991
`
`Applicant certifies micro entity status. See 37 CFR 1.29.
`Form PTO/SB/15A or B or equivalent must either be enclosed or have been submitted previously.
`.
`.
`m “not-i
`A check in the amount of the fee IS enclosed.
`H. F. . .......
`
`.
`.
`1 3:33 .5“
`
`Payment by credit card. Form PTO-203B is attached.
`
`The Director has already been authorized to charge fees in this application to a Deposit Account.
`The Director is hereby authorized to charge any fees which may be required. or credit any overpayment. to
`
`Deposit Account Number 19'0036
`
`Payment made via EFS-Web.
`
`WARNING: Information on this form may become public. Credit card information should not be included on this form. Provide
`credit card information and authorization on PTO-2038.
`I am the
`
`D applicant.
`attorney or agent of record. Registration number
`
`58.885
`
`D attorney or agent acting under 37 CFR 1.34. Registration number
`
`/Matthew S. Bodenstein/
`Signature
`
`Matthew S. Bodenstein
`Typed or printed name
`
`August 17, 2018
`
`(202) 371-2600
`
`Date
`
`Telephone Number
`
`NOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4 for signature requirements and certifications. Submit
`multile forms if more than one sionature is re-uired, see below“.
`
`" Total of
`
`1
`
`forms are submitted.
`
`This collection of information is required by 37 CFR 1.136(a). The information is required to obtain or retain a benefit by the public. which is to file (and by the
`USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 6 minutes to
`complete. including gathering. preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any
`comments on the amount of time you require to complete this form and/or suggestions for reducing this burden should be sent to the Chief Information Officer.
`U.S. Patent and Trademark Office, U.S. Department of Commerce, PO. Box 1450. Alexandria. VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS
`TO THIS ADDRESS. SEND TO: Mail Stop PCT. Commissioner for Patents, P.O. Box 1450. Alexandria, VA 22313-1450.
`
`